S-allylmercaptocysteine, a stable thioallyl compound, induces apoptosis in erythroleukemia cell lines

Nutrition and Cancer

Volumn 28, Issue 2, 1997, Pages 153-159

  Sigounas, George ^a   Hooker, Jerry L ^a   Li, Wei ^a   Anagnostou, Athanasius ^a   Steiner, Manfred ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; GARLIC EXTRACT; ORGANOSULFUR DERIVATIVE; S ALLYLMERCAPTOCYSTEINE; THYMIDINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; CYTOTOXICITY; DIAGNOSIS; DNA CONTENT; DOSE RESPONSE; ERYTHROLEUKEMIA CELL; ETIOLOGY; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL;

ALLIUM SATIVUM;

EID: 0030826223     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635589709514568     Document Type: Article

References (34)

1. Lin, RI: "Phytochemicals and antioxidants." In Functional Foods, I Goldberg (ed). New York: Chapman & Hall, 1994, pp 393-449.
2. Wargovich, MJ: "Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethylhydrazine-induced colon cancer." Carcinogenesis 8, 487-489, 1987.
3. Sparnins, VL, Barany, G, and Wattenberg, LW: "Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene-induced neoplasia and glutathione S-transferase activity in the mouse." Carcinogenesis 9, 131-134, 1988.
4. Brady, JF, Li, D, Ishizaki, H, and Yang, CS: "Effect of diallyl sulfide on rat liver microsomal nitrosamine metabolism and other monooxygenase activities." Cancer Res 48, 5937-5940, 1988.
5. Wargovich, MJ, Woods, C, Eng, VWS, Stephens, LC, and Gray, K: "Chemoprevention of N-nitrosomethylbenzylamine-induced esophageal cancer in rats by the naturally occurring thioether, diallysulfide." Cancer Res 48, 6872-6875, 1988.
6. Hu, P, and Wargovich, MJ: "Effect of diallyl sulfide on MNNG-induced nuclear aberrations and ornithine decarboxylase activity in the glandular stomach mucosa of the Wistar rat." Cancer Lett 47, 153-158, 1989.
7. Unnikrishnan, MC, and Kuttan, R: "Tumour reducing and anticarcinogenic activity of selected spices." Cancer Lett 51, 85-89, 1990.
8. Meng, C-L, and Shyu, K-W: "Inhibition of experimental carcinogenesis by painting with garlic extract." Nutr Cancer 14, 207-217, 1990.
9. Perchellet, J-P, Perchellet, EM, and Belman, S: "Inhibition of DMBA-induced mouse skin tumorigenesis by garlic oil and inhibition of two tumor-promotion stages by garlic and onion oils." Nutr Cancer 14, 183-193, 1990.
10. Ludeke, BI, Domine, F, Ohgaki, H, and Kleihues, P: "Modulation of N-nitrosomethylbenzylamine bioactivation by diallyl sulfide in vivo." Carcinogenesis 13, 2467-2470, 1992.
11. Ip, C, Lisk, DJ, and Stoewsand, GS: "Mammary cancer prevention by regular garlic and selenium-enriched garlic." Nutr Cancer 17, 279-286, 1992.
12. Sumiyoshi, H, and Wargovich, MJ: "Chemoprevention of 1,2-dimethylhydrazine-induced colon cancer in mice by naturally occurring organosulfur compounds." Cancer Res 50, 5084-5087, 1990.
13. Imai, J, Ide, N, Nagai, S, Moriguchi, T, Matsuura, H, et al.: "Antioxidant and radical scavenging effects of aged garlic extract and its constituents." Planta Med 60, 417-420, 1994.
14. Sigounas, G, Hooker, J, Anagnostou, A, and Steiner, M: "S-Allymercaptocysteine inhibits cell proliferation and reduces the viability of erythroleukemia and breast and prostate cancer cell lines." Nutr Cancer 27, 186-191, 1997.
15. Hayes, MA, Rushmore, TH, and Goldberg, MT: "Inhibition of hepatocarcinogenic responses to 1,2-dimethylhydrazine by diallyl sulfide, a component of garlic oil." Carcinogenesis 8, 1155-1157, 1987.
16. Marsh, CL, Torrey, RR, Wooley, JL, Barker, GR, and Lau, BHS: "Superiority of intravesicular immunotherapy with Corynebacterium parvum and Allium sativum in control of murine bladder cancer." J Urol 137, 359-362, 1987.
17. Shultz, PJ, DiCorleto, PE, Silver, BJ, and Abboud, HE: "Mesangial cells express PDGF mRNAs and proliferate in response to PDGF." Am J Physiol 255, F674-684, 1988.
18. Steiner, M: "Dynamics of platelet tubulin in response to changes in free sulfhydryl groups." Thromb Haemostas 53, 176-179, 1985.
19. Denizot, F, and Lang, R: "Rapid colorimetric assay for cell growth and survival. Modification to the tetrazolium dye procedure giving improved sensitivity and reliability." J Immunol Methods 89, 271-277, 1986.
20. Rodriguez, RE, Misra, M, Diwan, BA, Riggs, CW, and Kasprzak, KS: "Relative susceptibilities of C57BL/6, (C57BL/6×C3H/He)F1, and C3H/He mice to acute toxicity and carcinogenicity of nickel subsulfide." Toxicology 107, 131-140, 1996.
21. Mizutani, T, Nakahori, Y, and Yamamoto, K: "p-Dichlorobenzene-induced hepatoxicity in mice depleted of glutathione by treatment with buthionine sulfoximine." Toxicology 94, 57-67, 1994.
22. Tsuda, H, Uehara, N, Iwahori, Y, Asamoto, M, Iigo, M, et al.: "Chemopreventive effects of beta-carotene, alpha-tocopherol and five naturally occurring antioxidants on initiation of hepatocarcinogenesis by 2-amino-3-methylimidazo[4,5-f]quinoline in the rat." Jpn J Cancer Res 85, 1214-1219, 1994.
23. Monks, TJ, and Lau, SS: "Glutathione conjugation as a mechanism for the transport of reactive metabolites." Adv Pharmacol 27, 183-210, 1994.
24. Zhang, L, and Mock, D: "Alterations in glutathione level during carcinogenesis of hamster buccal pouch mucosa." J Dent Res 70, 1061-1063, 1991.
25. Engin, A: "Glutathione content of human skin carcinomas." Arch Dermatol Res 257, 53-55, 1976.
26. Hosking, LK, Whelan, DH, Shellard, SA, Bedford, P, and Hill, BT: "An evaluation of the role of glutathione and its associated enzymes in the expression of differential sensitivities to antitumor agents shown by a range of human tumor cell lines." Biochem Pharmacol 40, 1833-1842, 1990.
27. Mistry, P, Kelland, LR, Abel, G, Sidhar, S, and Harrap, KR: "The relationship between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian cell lines." Br J Cancer 6, 215-220, 1991.
28. Yellin, SA, Davidson, BJ, Pinto, JT, Sacks, PG, Qiao, C, et al.: "Relationship of glutathione and glutathione-S-transferase to cisplatin sensitivity in human head and neck squamous carcinoma cell lines." Cancer Lett 85, 223-232, 1994.
29. Dive, C, and Wyllie, AH: "Apoptosis and cancer chemotherapy." In Frontiers in Pharmacology, JA Hickman and TT Tritton (eds). Oxford: Blackwell Scientific, 1993, pp 21-56.
30. Lennon, SV, Martin, SJ, and Cotter, TG: "Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli." Cell Prolif 24, 203-214, 1991.
31. Meikrantz, W, and Schlegel, R: "Apoptosis and the cell cycle." J Cell Biochem 58, 160-174, 1995.
32. Patel, T, Gores, GJ, and Kaufmann, SH: "The role of proteases during apoptosis." FASEB J 10, 587-597, 1996.
33. Matsukawa, Y, Marui, N, Sakai, T, Satomi, Y, Yoshida, M, et al.: "Genistein arrests cell cycle progression at G2-M." Cancer Res 53, 1328-1331, 1993.
34. Ishigami, T, Kim, K-M, Horiguchi, Y, Higaki, Y, Hata, D, et al.: "Anti-IgM antibody-induced cell death in human B lymphoma cell line B104 represents a novel programmed cell death." J Immunol 148, 360-368, 1992.